Genetics Frontiers

Explore breakthrough studies and innovative genomic research

Research Articles

Umbralisib: A Dual-Pronged Weapon Against Relapsed Lymphoma

Explore Umbralisib's dual-inhibition approach in treating relapsed/refractory indolent non-Hodgkin lymphoma through the UNITY-NHL trial data and findings.

Joshua Mitchell
Oct 15, 2025

The Double-Edged Sword: When the Body's Defense Force Turns Against It

Exploring the groundbreaking research linking autoimmune diseases to increased lymphoma risk through real-world evidence analysis.

Addison Parker
Oct 10, 2025

Popular Articles